ARS Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
/ 
Frequently asked questions
To buy ARS Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ARS Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ARS Pharmaceuticals Inc. is SPRY:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ARS Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade ARS Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ARS Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ARS Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ARS Pharmaceuticals Inc..